Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity

Hepatology

Volumn 48, Issue 5, 2008, Pages 1420-1429

  Miura, Kouichi ^a   Taura, Kojiro ^a   Kodama, Yuzo ^a   Schnabl, Bernd ^a   Brenner, David A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CCAAT ENHANCER BINDING PROTEIN ALPHA; HEPCIDIN; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROTEIN VP3; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; ANTIMICROBIAL CATIONIC PEPTIDE; SMALL INTERFERING RNA;

ACETYLATION; ADENOVIRUS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REGULATORY MECHANISM; REPLICON; CELL LINE; GENETIC TRANSCRIPTION; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

ANTIMICROBIAL CATIONIC PEPTIDES; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE; HEPACIVIRUS; HISTONE DEACETYLASES; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 56149115918     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22486     Document Type: Article

References (39)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-714.
2. She H, Xiong S, Lin M, Zandi E, Giulivi C, Tsukamoto H. Iron activates NF-kB in Kupffer cells. Am J Physiol Gastrointest Liver Physiol 2002;283: G719-G726.
3. Gardi C, Arezzini B, Fortino V, Comporti M. Effect of free iron on collagen synthesis, cell proliferation and MMP-2 expression in rat hepatic stellate cells. Biochem Pharma 2002;64:1139-1145.
4. Alla V, Bonkovsky HL. Iron in nonhemochromatic liver disorders. Semin Liver Dis 2005;25:461-472.
5. Pietrangelo A. Iron chelation beyond transfusion iron overload. Am J Hematol. 2007;82:1142-1146.
6. Kawamura Y, Akuta N, Sezaki H, Hosaka T, Someya T, Kobayashi M, et al. Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection. J Gastroenterol 2005;40:901-906.
7. Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takitomo R, et al. Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine level in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 2001,61:8697-8702.
8. Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, et al. Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, control trial. HEPATOLOGY 2000;31: 730-736.
9. Kageyama F, Kobayashi Y, Kawasaki T, Toyokuni S, Uchida K, Nakamura H. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 2000;95:1041-1050.
10. Furutani T, Hino K, Okuda M, Gondo T, Nishina S, Kitase A, et al. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 2006;130: 2087-2098.
11. Roy CN, Mak HH, Akpan I, Losyev G, Zurakowski D, Andrews NC. Hepcidin antimicrobial peptide transgenic mice exhibit feature of the anemia of inflammation. Blood 2007;109:4038-4044.
12. Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, Houbron C, et al. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 2006;108:1402-1405.
13. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006;26:323-342.
14. Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H, et al. Hepcidin expression in the liver: Relatively low level in patients with chronic hepatitis C. Mol Med 2007;13:97-104.
15. Nagashima M, Kudo M, Chung H, Ishikawa E, Hagiwara S, Nakatani T, et al. Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res 2006;36:288-293.
16. Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, Mizukami Y, et al. Hepatitis C virus-induced reactive oxygen stress raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 2008;134: 226-238.
17. Choi SO, Cho YS, Kim HL, Park JW. ROS mediated the hypoxic repression of the hepcidin gene by inhibiting C/EBPα and STAT3. Biochem Biophys Res Commun 2007;356:312-317.
18. Harrison-Findik DD, Schafer D, Klein E, Timchenko NA, Kulaksiz H, Clemens D, et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem 2006;281:22974-22982.
19. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, et al. Regulation of iron homeostasis by the hypoxia-inducible transcriptional factors (HIFs). J Clin Invest 2007;117:1926-1932.
20. Li Y, Boehning DF, Qian T, Popov VL, Weinman SA. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. FASEB J 2007;21:2474-2485.
21. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122: 366-375.
22. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002;76: 13001-13014.
23. Bataller R, Paik YH, Lindquist JN, Lemasters JJ, Brenner DA. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 2004;126:529-540.
24. Sengupta N, Seto E. Regulation of histone deacetylase activities. J Cell Biol 2004;93:56-67.
25. Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007;26:5541-5552.
26. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006;70:1469-1480.
27. Seifeddine R, Dreiem A, Blanc E, Fulchignoni-Lataud MC, Le Frère Belda AU, Lecuru F, et al. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells. Cancer Res 2008;68:2158-2165.
28. Carrière A, Carmona MC, Fernandez Y, Rigoulet M, Wenger RH, Pénicaud l, et al. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: A mechanism for hypoxia-dependent effect. J Biol Chem 2004;279:40462-40469.
29. Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, Corradini E, et al. STAT3 is required for IL6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 2007;132:294-300.
30. Cua IHY, Hui JM, Bandara P, Kench JG, Farrell GC, McCaughan GW, et al. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. HEPATOLOGY 2007;46:66-73.
31. Choi J, Ou JHJ. Mechanism of liver injury III: Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 2006;290:G847-G851.
32. Rahman I. Oxidative stress,chromatin remodeling and gene transcription in inflammatory and chronic lung diseases. J Biochem Mol Biol 2003;31: 95-109.
33. Berthiaume M, Boufaied N, Moisan A, Gaudreau L. High levels of oxidative stress globally inhibit gene transcription and histone acetylation. DNA Cell Biol. 2006;25:124-134.
34. Qian DZ, Kachhap SK, Collis SJ, VerheulHMW,Carducci MA, Atadja P, et al Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α. Cancer Res 2006; 66:8814-8821.
35. Kato H, Tamamizu-Kato S, Futoshi Shibasaki F. Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity. J Biol Chem 2004;279:41966-41974.
36. Nasimuzzaman M, Waris G, Mikolon D, Stupack DG, Siddiqui A. Hepatitis C virus stabilizes hypoxia-inducible factor 1α and stimulates the synthesis of vascular endothelial growth factor. J Virol 2007;81:10249-10257.
37. Beltrami EM, Williams IT, Shapiro CN, Chamberland ME. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev 2000;13:385-407.
38. Gabbay E, Zigmond E, Pappo O, Hemed N, Rowe M, Zabrecky G. Antioxidant therapy for chronic hepatitis C after failure of interferon: Results of phase II randomized, double-blind placebo controlled clinical trial. World J Gastroenterol 2007;13:5317-5323.
39. Niki T, Rombouts K, Bleser PD, De Smet K, Rogiers V, Schuppan D, et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. HEPATOLOGY 1999;29:858-867.